DRUG · Mapped RxNorm record
Semaglutide
Normalized identity: semaglutideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
NCT05768945
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
DPP-4 inhibitor
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedData Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Semaglutide v DPP4 Inhibitors
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetesverified · MONDO: diabetes mellitus
Interventions
SemaglutideDRUG · verified · RxNorm: semaglutide
DPP-4 inhibitorDRUG
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
National Institute on Aging (NIA)collaborator
Rutgers Universitycollaborator
Johns Hopkins Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05768945 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.